1 of 35

Seoul National University Bundang Hospital, Republic of Korea

Younbeom Jeong, Yun Jung Bae

Advanced Staging of Nasopharyngeal Carcinoma

in the AJCC 9th Edition: Implications for Radiologists

2 of 35

Introduction

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • Nasopharyngeal carcinoma (NPC) is a radiosensitive malignancy typically managed with chemoradiation, making imaging-based staging essential.
  • The AJCC 9th Edition for NPC, released in 2024, continues to treat nasopharyngeal cancer as a distinct staging entity, now published as a site-specific monograph separate from other head and neck cancers.
  • Radiologists are pivotal in NPC staging, as most criteria rely on MRI and CT interpretation rather than surgical pathology.
  • This exhibit reviews the updated staging system with imaging examples and tips to enhance diagnostic accuracy and reporting consistency.

3 of 35

Objectives

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  1. Review recent updates to the AJCC 9th Edition staging system for nasopharyngeal carcinoma.
  2. Recognize key imaging features relevant to T and N category staging.
  3. Improve confidence in applying updated staging criteria to radiologic reporting.

4 of 35

Overview of Staging Updates

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • AJCC 9th Edition reflects advances in risk stratification and imaging-based staging of NPC.
  • Key changes focus on refined definitions of T3 and N3 categories.
  • Other categories remain largely consistent with the 8th Edition.
  • No change in M category, but future editions may refine oligometastatic disease definitions.
  • Imaging interpretation now directly influences staging more than ever.

Category

AJCC 8th Edition

AJCC 9th Edition

Key Changes

T3

Bone invasion

(not clearly defined)

Unequivocal bone invasion required

Must show cortical destruction or marrow involvement

N3

Nodal size ≥6 cm or supraclavicular

Advanced ENE newly included

ENE with invasion of muscle, vessels, skin

T4 / N1 / M

No major change

No major change

5 of 35

T Category – Key Points

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • T staging in nasopharyngeal carcinoma is based on the anatomic extent of tumor spread.
  • The major revision involves a clarified definition of T3 bone invasion.
    • imaging evidence of definite bone invasion — not just sclerosis or abutment

Category

AJCC 8th Edition

AJCC 9th Edition

T3

Tumor with infiltration of bony structures at skull base, cervical vertebra, pterygoid structures, and/or paranasal sinuses

Tumor with unequivocal infiltration into any of the following bony structures: (1) skull base (including pterygoid structures); (2) paranasal sinuses; (3) cervical vertebrae

6 of 35

T Category – Key Points

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • New clarification: Inferior orbital fissure (IOF) involvement is now explicitly categorized as T4.
  • Cranial nerve involvement must be unequivocal (radiologic and/or clinical) to qualify as T4.

Category

AJCC 8th Edition

AJCC 9th Edition

T4

Tumor with intracranial extension, involvement of cranial nerves, hypopharynx, orbit, parotid gland, and/or extensive soft tissue infiltration beyond the lateral surface of the lateral pterygoid muscle

Tumor with any of the following extension/involvement: (1) intracranial extension; (2) unequivocal radiological and/or clinical involvement of cranial nerves; (3) hypopharynx; (4) orbit (including inferior orbital fissure); (5) parotid gland; (6) extensive soft tissue infiltration beyond the anterolateral surface of the lateral pterygoid muscle

7 of 35

T Category – Staging Landmarks

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • T staging is based on the anatomic extent of tumor spread.
  • Accurate identification of bone invasion, parapharyngeal extension, and cranial nerve involvement is essential.
  • Both MRI and CT should be used complementarily to improve staging precision.

Involvement

T1

T2

T3

T4

Nasal cavity / Oropharynx

+/-

+/-

+/-

+/-

Parapharyngeal fat

-

+

+/-

+/-

Medial/lateral pterygoid or prevertebral muscle

-

+

+/-

+/-

Skull base or cervical vertebra

-

-

+

+/-

Paranasal sinus

-

-

+

+/-

Cranial nerve involvement / intracranial extension

-

-

-

+

Orbit (+ Inferior orbital fissure) / Hypopharynx / Parotid gland

-

-

-

+

Beyond anterolateral surface of lateral pterygoid muscle

-

-

-

+

8 of 35

T Category – T2: Parapharyngeal Extension

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • The parapharyngeal space is a fat-filled space lateral to the superior pharyngeal constrictor muscle and medial to the medial pterygoid muscle.

Imaging Tip:

  • Loss of the fat plane between the tumor and parapharyngeal space
  • Displacement or obliteration of the parapharyngeal fat pad
  • Use T1WI without fat saturation to assess preserved fat planes
  • Parapharyngeal extension = T2, regardless of involvement depth

9 of 35

T Category – T3: Unequivocal Bone Invasion

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • T3 requires unequivocal bone invasion of the skull base, cervical vertebrae, or paranasal sinuses.
  • Imaging must show cortical destruction or marrow signal abnormality, not just contact or sclerosis.

Imaging Tip:

  • CT is preferred for cortical breach (d)
  • MRI is sensitive for marrow infiltration (a,b)

(a)

(b)

(c)

(d)

10 of 35

T Category – T4: IOF Involvement

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • Inferior orbital fissure (IOF) is the junction between the orbit and pterygopalatine fossa.

Imaging Tip:

  • Use axial and coronal T1WI with contrast to evaluate tumor abutment or invasion of the IOF
  • Loss of the bony cortex, soft tissue extension into or through the IOF, or fat infiltration = suggestive of IOF involvement
  • Not be confused with pterygopalatine fossa or infratemporal fossa extension alone

11 of 35

T Category – T4: Cranial Nerve Involvement

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • Involvement of cranial nerves, particularly CN V (V2/V3) and CN VI
  • Only unequivocal perineural spread, either radiologic or clinical, qualifies

Imaging Tip:

  • Track tumor along foramina:
    • Foramen rotundum (V2)
    • Foramen ovale (V3)
    • Dorello’s canal (CN VI)
  • Look for nerve thickening, enhancement, or extension to Meckel’s cave, cavernous sinus
  • Use contrast-enhanced T1WI with fat suppression

Foramen ovale / Meckel's cave

Foramen rotundum

12 of 35

N Category – Key Points

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • N staging is determined by size, laterality, location, and now, presence of advanced extranodal extension (ENE).
  • AJCC 9th Edition adds radiologic advanced ENE as a defining feature of N3 disease.
  • Accurate assessment of ENE on imaging is essential for proper nodal staging.

Category

AJCC 8th Edition

AJCC 9th Edition

Key Changes

N1

Unilateral metastasis in cervical lymph node(s) and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), ≤6 cm, above the caudal border of the cricoid cartilage

Same

+ without advanced extranodal extension

Explicit exclusion of advanced ENE

N2

Bilateral cervical LN(s), ≤6 cm, above cricoid

Same

+ without advanced extranodal extension

Explicit exclusion of advanced ENE

N3

LN(s) >6 cm or supraclavicular fossa involvement

>6 cm, supraclavicular fossa involvement, or advanced ENE

Advanced ENE added as criterion

13 of 35

N Category – Advanced ENE

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • Advanced ENE is defined as unequivocal radiologic evidence of tumor extension beyond the lymph node capsule.
  • It must involve adjacent structures, such as:
    • Skeletal muscle (e.g., sternocleidomastoid)
    • Skin
    • Neurovascular bundles
  • Pathologic confirmation is not required — radiologic diagnosis alone is sufficient.
  • The following features do not meet the criteria for advanced ENE
    • Irregular or indistinct nodal margins
    • Perinodal fat stranding
    • Adjacent nodal matting / conglomeration
    • Coalescent or matted nodes
    • ENE of retropharyngeal lymph nodes (explicitly excluded)

14 of 35

N Category – Advanced ENE

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Imaging Tip:

Direct invasion into the ipsilateral internal jugular vein, scalene muscle, and sternocleidomastoid muscle

15 of 35

Tips for Radiologic Reporting

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • Systematic search and structured reporting are essential for accurate AJCC 9th Edition staging in NPC.
  • Begin at the primary site and evaluate tumor spread directionally, referencing key anatomic landmarks from the T category.
  • Assess nodal involvement by size, laterality, level, and features of advanced extranodal extension (ENE).
  • Align reporting with staging criteria by describing what structures are involved, not just the stage label.

16 of 35

Tips for Radiologic Reporting

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  • Reporting Check List for T/N Staging

Anatomical Site

Check Point

Check

Tumor Extent

Oropharynx or nasal cavity

Parapharyngeal space

Medial/lateral pterygoid or prevertebral muscles

Skull base / Cervical vertebra / Paranasal sinuses

Unequivocal bone invasion

Orbit

Including IOF

Intracranial extension

Cranial nerve

Unequivocal involvement

Hypopharynx / Parotid gland

Beyond anterolateral surface of lateral pterygoid muscle

Node Involvement

Laterality (Unilateral vs. Bilateral)

Node levels and size

N1, N2: Above the caudal border of the cricoid cartilage

Supraclavicular fossa involvement

Advanced ENE

Skeletal muscles invasion

Retropharyngeal ENE does not qualify for N3

Skin invasion

Neurovascular bundle invasion

17 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 1 (69/F)

18 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 1 (69/F)

19 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Anatomical Site

Check

Tumor Extent

Oropharynx or nasal cavity

X

Parapharyngeal space

Medial/lateral pterygoid or prevertebral muscles

✓ (Prevertebral muscle)

Skull base / Cervical vertebra / Paranasal sinuses

✓ (Unequivocal Invasion)

Orbit

X

Case 1 (69/F)

20 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Anatomical Site

Check

Tumor Extent

Oropharynx or nasal cavity

X

Parapharyngeal space

Medial/lateral pterygoid or prevertebral muscles

✓ (Prevertebral muscle)

Skull base / Cervical vertebra / Paranasal sinuses

✓ (Unequivocal Invasion)

Orbit

X

Case 1 (69/F)

Answer: T3

21 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 2 (74/M)

5.5cm

22 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 2 (74/M)

5.5cm

23 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 2 (74/M)

Anatomical Site

Check

Tumor Extent

Oropharynx or nasal cavity

✓ (Oropharynx)

Parapharyngeal space

Node Involvement

Laterality (Unilateral vs. Bilateral)

✓ (Bilateral)

Node levels and size

✓ (Rt. level V, both level II, <6cm)

Supraclavicular fossa involvement

X

Advanced ENE

Skeletal muscles invasion

X (Lt. level II conglomerated LNs)

Skin invasion

X

Neurovascular bundle invasion

X

24 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 2 (74/M)

Anatomical Site

Check

Tumor Extent

Oropharynx or nasal cavity

✓ (Oropharynx)

Parapharyngeal space

Node Involvement

Laterality (Unilateral vs. Bilateral)

✓ (Bilateral)

Node levels and size

✓ (Rt. level V, both level II, <6cm)

Supraclavicular fossa involvement

X

Advanced ENE

Skeletal muscles invasion

X (Lt. level II conglomerated LNs)

Skin invasion

X

Neurovascular bundle invasion

X

Answer: T2N2

25 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 3 (63/M)

26 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 3 (63/M)

27 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 3 (63/M)

Anatomical Site

Check

Tumor Extent

Parapharyngeal space

Medial/lateral pterygoid or prevertebral muscles

✓ (Prevertebral muscle)

Node Involvement

Laterality (Unilateral vs. Bilateral)

✓ (Unilateral)

Node levels and size

✓ (Lt. level II/III/IV)

Advanced ENE

Skeletal muscles invasion

✓ (SCM Scalene muscle )

Skin invasion

X

Neurovascular bundle invasion

X

28 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 3 (63/M)

Anatomical Site

Check

Tumor Extent

Parapharyngeal space

Medial/lateral pterygoid or prevertebral muscles

✓ (Prevertebral muscle)

Node Involvement

Laterality (Unilateral vs. Bilateral)

✓ (Unilateral)

Node levels and size

✓ (Lt. level II/III/IV)

Advanced ENE

Skeletal muscles invasion

✓ (SCM Scalene muscle )

Skin invasion

X

Neurovascular bundle invasion

X

Answer: T2N3

29 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 4 (67/M)

30 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 4 (67/M)

Foramen ovale

Meckel's cave

31 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 4 (67/M)

Anatomical Site

Check

Tumor Extent

Parapharyngeal space

Skull base / Cervical vertebra / Paranasal sinuses

✓ (Unequivocal Invasion)

Cranial nerve

✓ (CN V3 CN V )

Node Involvement

Laterality (Unilateral vs. Bilateral)

Unilateral

Node levels and size

✓ Rt. retropharyngeal, <6cm

Supraclavicular fossa involvement

X

32 of 35

Staging Exercise

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Case 4 (67/M)

Anatomical Site

Check

Tumor Extent

Parapharyngeal space

Skull base / Cervical vertebra / Paranasal sinuses

✓ (Unequivocal Invasion)

Cranial nerve

✓ (CN V3 CN V )

Node Involvement

Laterality (Unilateral vs. Bilateral)

Unilateral

Node levels and size

✓ Rt. retropharyngeal, <6cm

Supraclavicular fossa involvement

X

Answer: T4N1

33 of 35

Summary

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

T Category

  • AJCC 9th Edition emphasizes clear bone involvement as the threshold for T3.
  • Unequivocal cranial nerve involvement (particularly CN V and VI) or intracranial extension qualifies as T4.

→ Look for perineural spread via foramen rotundum, ovale, or into Meckel’s cave.

  • IOF involvement is explicitly classified as T4, resolving prior ambiguity.

N Category

  • Advanced ENE (muscle, vessel, skin invasion) is now included as a criterion for N3.
  • Fat stranding or irregular margins alone ≠ advanced ENE.
  • Retropharyngeal ENE is excluded from N3 criteria.

34 of 35

Summary

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

Reporting Tips

  • Use a structured, anatomy-based approach aligned with AJCC 9th Edition.
  • Always specify:
    • Involved structures
    • Nodal location, laterality, size, and ENE features
  • Avoid vague terms; be definitive when features meet criteria (e.g., “muscle invasion,” “perineural spread”).

“Accurate staging begins at the radiologist’s desk.”

35 of 35

References

Introduction

Objectives

Overview

T Category

N Category

Tips for Report

Summary

References

  1. Amin MB, Edge SB, Greene FL, et al, eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.
  2. Pan JJ, Mai HQ, Ng WT, et al. Ninth version of the AJCC and UICC nasopharyngeal cancer TNM staging classification. JAMA Oncol. 2024;10:1627.
  3. Lee A, Huang SH, Chua M, American Joint Committee on Cancer. AJCC Cancer Staging System: Nasopharynx. American Joint Committee on Cancer; 2025.
  4. Rai S, Xu CC, Olsen S, et al. The 9th version of the AJCC staging system for nasopharyngeal carcinoma: a guide for radiologists. AJR Am J Roentgenol. Published online 2025. doi:10.2214/AJR.25.33016
  5. Razek AAKA, King A. MRI and CT of nasopharyngeal carcinoma. Am J Roentgenol. 2012;198:11–18.
  6. Yu E, O’Sullivan B, Kim J, Siu L, Bartley E. Magnetic resonance imaging of nasopharyngeal carcinoma. Expert Rev Anticancer Ther. 2010;10:365–375.
  7. Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol. 2015;32:54–73.
  8. Pan JJ, Ng WT, Zong JF, et al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016;122:546–558.
  9. Xiao Y, Pan J, Chen Y, et al. The prognosis of nasopharyngeal carcinoma involving masticatory muscles: a retrospective analysis for revising T subclassifications. Medicine (Baltimore). 2015;94:e420.
  10. Feng AC, Wu MC, Tsai SY, et al. Prevertebral muscle involvement in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;65:1026–1035.
  11. Goh J, Lim K. Imaging of nasopharyngeal carcinoma. Ann Acad Med Singapore. 2009;38:809–816.
  12. Glastonbury CM, Salzman KL. Pitfalls in the staging of cancer of nasopharyngeal carcinoma. Neuroimaging Clin N Am. 2013;23:9–25.
  13. Medvedev O, Hedesiu M, Ciurea A, et al. Perineural spread in head-and-neck malignancies: imaging findings – an updated literature review. Bosn J Basic Med Sci. 2022;22:22–38.